Insulet Corporation carries a market capitalization of 10.37B, placing it among publicly traded companies globally. Its enterprise value stands at 15.21B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.37B |
| Enterprise Value | 15.21B |
Insulet Corporation currently has 69.26M shares outstanding.
| Shares Outstanding | 69.26M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Insulet Corporation trades at a trailing price-to-earnings ratio of 48.70. The price-to-sales ratio is 5.08, and the price-to-book ratio stands at 38.95.
| PE Ratio | 48.70 |
| PS Ratio | 5.08 |
| PB Ratio | 38.95 |
| P/TBV Ratio | 12.98 |
| P/FCF Ratio | 22.87 |
| P/OCF Ratio | 23.81 |
On an enterprise value basis, Insulet Corporation trades at an EV/EBITDA multiple of 25.26 and an EV/FCF ratio of 21.87. The EV/Sales ratio of 5.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.99 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.24 |
| EV / EBITDA | 25.26 |
| EV / EBIT | 29.99 |
| EV / FCF | 21.87 |
Insulet Corporation maintains a current ratio of 2.49, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 72.79, indicating elevated leverage, while an interest coverage ratio of 9.29 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.49 |
| Quick Ratio | 1.49 |
| Debt / Equity | 72.79 |
| Debt / EBITDA | 1.57 |
| Interest Coverage | 9.29 |
Insulet Corporation posts a return on equity of 133.27 and a return on invested capital of 14.40.
| Return on Equity (ROE) | 133.27 |
| Return on Assets (ROA) | 9.31 |
| Return on Invested Capital (ROIC) | 14.40 |
| Return on Capital Employed (ROCE) | 22.68 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.86 |
Over the trailing twelve months, Insulet Corporation has paid 101.50M in income taxes, reflecting an effective tax rate of 25.10.
| Income Tax | 101.50M |
| Effective Tax Rate | 25.10 |
Insulet Corporation's stock has declined approximately -51.17258% over the past 52 weeks. The 50-day moving average sits at 169.67, while the 200-day moving average is 260.28.
| Beta (5Y) | N/A |
| 52-Week Price Change | -51.17258% |
| 50-Day Moving Average | 169.67 |
| 200-Day Moving Average | 260.28 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Insulet Corporation generated 2.90B in revenue and converted that into 302.80M in net income, yielding earnings per share of 4.29. EBITDA reached 602.20M, while operating income came in at 507.30M.
| Revenue | 2.90B |
| Gross Profit | 2.06B |
| Operating Income | 507.30M |
| Pretax Income | 404.40M |
| Net Income | 302.80M |
| EBITDA | 602.20M |
| EBIT | 507.30M |
| Earnings Per Share (EPS) | 4.29 |
Insulet Corporation holds 480.40M in cash and equivalents against 948.10M in total debt, resulting in a net debt position of 467.70M. Total book value stands at 378.60M, with working capital of 1.02B providing operational flexibility.
| Cash & Cash Equivalents | 480.40M |
| Total Debt | 948.10M |
| Net Debt | 467.70M |
| Equity (Book Value) | 378.60M |
| Book Value Per Share | 5.39 |
| Working Capital | 1.02B |
Insulet Corporation produced 619.30M in operating cash flow over the past twelve months. After subtracting -27.90M in capital expenditures, free cash flow totaled 591.40M - equivalent to 8.42 per share.
| Operating Cash Flow | 619.30M |
| Capital Expenditures | -27.90M |
| Free Cash Flow | 591.40M |
| FCF Per Share | 8.42 |
Insulet Corporation operates with a gross margin of 71.01, reflecting its pricing power and cost economics. The operating margin of 17.49 and net profit margin of 10.44 provide insight into operational efficiency.
| Gross Margin | 71.01 |
| Operating Margin | 17.49 |
| Pretax Margin | 13.94 |
| Profit Margin | 10.44 |
| EBITDA Margin | 20.76 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 8.09 |
| FCF Yield | 4.37 |
Insulet Corporation posts an Altman Z-Score of 7.50, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.50 |